Becker's Healthcare January 4, 2022
Georgina Gonzalez

The FDA has published a draft document that advises on the use of digital health tools in acquiring data from participants in clinical investigations that evaluate medical products.

In the document, issued Jan. 3, the agency says advances in technology have boosted the power of data collection methodology in clinical investigations and allow for more detailed recordings of participants’ daily lives.

“Compared to intermittent trial visits,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, FDA, Govt Agencies, Technology
FDA advisers to weigh first psychedelic therapy in early June
Masimo’s at-home baby monitor cleared for use without prescription
Apple Watch's AFib detection tool earns landmark FDA approval
FDA flags 10 observations in another Form 483 for a Zydus plant
FDA targets cancer drugs to be less toxic, more cost effective

Share This Article